Life sciences & healthcare
Your critical work, moving with clarity.
A senior activation practice for life sciences and healthcare leaders. We step inside the work where launches, integrations, and priorities can't afford to drift, and stay until the work runs without us.
Where activation matters
What changes when the work is moving.
Your critical work competing with everything else
The work that matters most gets focus, and carries through.
Your plans looking right, but not holding
The work holds up across teams, pressure, and change.
Your organization getting louder, not clearer
Ownership is clear; escalations drop, and the work moves.
Your progress depending on outside support
Teams are internally aligned and able to sustain the work on their own.
Industry-wide, healthcare and life sciences leaders are
operating inside these odds every day.
56–60%
of drug launches miss their pre-launch expectations
9 in 10
AI pilots in biopharma never reach production
60–75%
of pharma M&A deals fail to deliver the expected returns
16%
of digital transformations deliver sustained benefits on time

30+
large-scale transformations led
$500M+
programs operated
9-figure
accountability
5
executive teams advised
About Frank Traina
Thirty years inside the work that can't drift.
A senior operator with nearly three decades at Accenture, EY, and Veeva, Frank has led nine-figure transformations, integrations, and regulation-constrained industry scenarios, and built an advanced therapies platform from concept to enterprise adoption.
Today he brings that Fortune 50 operating experience to industry leaders, without the twenty-person consulting team.
I write about the work directly: pressure, failed structures, and what actually moves organizations forward.
Read my field notes →Selected activations.

Global top-tier biopharma
Three-platform activation
Activating three mission-critical platforms in parallel, at global enterprise scale. Regulatory, clinical, and quality transitioned off legacy infrastructure with no break in operations.

Advanced therapies program
Operating model
Activating end-to-end visibility where failure has no second chance. Contributed to a ~$500M enterprise asset supporting thousands of patients across hundreds of sites.